Global CAR-T Cell Therapy Drugs Supply, Demand and Key Producers, 2026-2032
The global CAR-T Cell Therapy Drugs market size is expected to reach $ 7888 million by 2032, rising at a market growth of 9.6% CAGR during the forecast period (2026-2032).
CAR-T cell therapy is a personalized live cell therapy based on genetically engineered T cells from a patient. The patient's T cells are extracted in vitro and the chimeric antigen receptor (CAR) gene is introduced using viral or non-viral vectors, giving them the ability to specifically recognize and attack tumor cells. After in vitro expansion, these cells are reinfused into the patient, achieving precise immune clearance of hematologic malignancies and even some solid tumors. This therapy is essentially a 'living drug,' possessing the triple attributes of cell therapy, gene therapy, and immunotherapy.
The CAR-T industry chain can be divided into three main segments: upstream core raw materials and technology platforms, midstream cell therapy development and manufacturing, and downstream clinical application and commercialization. The upstream segment includes key consumables and tools such as viral vectors, plasmid DNA, cell culture media, disposable bioreactors, automated closed cell preparation equipment, and quality control reagents. The midstream segment encompasses CAR gene design and optimization, T cell collection, gene transduction, cell expansion, quality control, and GMP-level production systems. The downstream segment involves patient screening, lymph node dissection chemotherapy, cell reinfusion, and adverse reaction management in hospital hematology/oncology centers. It also involves medical insurance payments, commercial insurance, and high-value drug access systems, forming a closed-loop ecosystem of 'patient customization + highly GMP manufacturing + high-barrier medical services.'
The CAR-T industry is at a critical inflection point, transitioning from 'breakthrough therapy for hematologic malignancies' to 'expansion into solid tumors and autoimmune diseases.' Future growth will be driven by expanding indications, technological upgrades, reduced manufacturing costs, and the gradual liberalization of global payment systems. With the maturation of automated production, non-viral vector technologies, and large-scale CDMO systems, CAR-T is expected to gradually move from the current ultra-high-cost 'personalized customized therapy' to 'quasi-large-scale biologics.' The long-term market potential is projected to exceed tens of billions of US dollars, and it will form a competitive and complementary relationship with bispecific antibodies, TCR-T, and ADCs in tumor immunotherapy.
This report studies the global CAR-T Cell Therapy Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CAR-T Cell Therapy Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of CAR-T Cell Therapy Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CAR-T Cell Therapy Drugs total market, 2021-2032, (USD Million)
Global CAR-T Cell Therapy Drugs total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: CAR-T Cell Therapy Drugs total market, key domestic companies, and share, (USD Million)
Global CAR-T Cell Therapy Drugs revenue by player, revenue and market share 2021-2026, (USD Million)
Global CAR-T Cell Therapy Drugs total market by Targets, CAGR, 2021-2032, (USD Million)
Global CAR-T Cell Therapy Drugs total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global CAR-T Cell Therapy Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Kite Pharma, Bristol Myers Squibb?BMS?, Gilead Sciences, Johnson & Johnson, Legend Biotech, Fosun Kite, JW Therapeutics, IASO Biotherapeutics, Juventas Cell Therapy, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world CAR-T Cell Therapy Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Targets, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global CAR-T Cell Therapy Drugs Market, By Region:
1. How big is the global CAR-T Cell Therapy Drugs market?
2. What is the demand of the global CAR-T Cell Therapy Drugs market?
3. What is the year over year growth of the global CAR-T Cell Therapy Drugs market?
4. What is the total value of the global CAR-T Cell Therapy Drugs market?
5. Who are the Major Players in the global CAR-T Cell Therapy Drugs market?
6. What are the growth factors driving the market demand?
CAR-T cell therapy is a personalized live cell therapy based on genetically engineered T cells from a patient. The patient's T cells are extracted in vitro and the chimeric antigen receptor (CAR) gene is introduced using viral or non-viral vectors, giving them the ability to specifically recognize and attack tumor cells. After in vitro expansion, these cells are reinfused into the patient, achieving precise immune clearance of hematologic malignancies and even some solid tumors. This therapy is essentially a 'living drug,' possessing the triple attributes of cell therapy, gene therapy, and immunotherapy.
The CAR-T industry chain can be divided into three main segments: upstream core raw materials and technology platforms, midstream cell therapy development and manufacturing, and downstream clinical application and commercialization. The upstream segment includes key consumables and tools such as viral vectors, plasmid DNA, cell culture media, disposable bioreactors, automated closed cell preparation equipment, and quality control reagents. The midstream segment encompasses CAR gene design and optimization, T cell collection, gene transduction, cell expansion, quality control, and GMP-level production systems. The downstream segment involves patient screening, lymph node dissection chemotherapy, cell reinfusion, and adverse reaction management in hospital hematology/oncology centers. It also involves medical insurance payments, commercial insurance, and high-value drug access systems, forming a closed-loop ecosystem of 'patient customization + highly GMP manufacturing + high-barrier medical services.'
The CAR-T industry is at a critical inflection point, transitioning from 'breakthrough therapy for hematologic malignancies' to 'expansion into solid tumors and autoimmune diseases.' Future growth will be driven by expanding indications, technological upgrades, reduced manufacturing costs, and the gradual liberalization of global payment systems. With the maturation of automated production, non-viral vector technologies, and large-scale CDMO systems, CAR-T is expected to gradually move from the current ultra-high-cost 'personalized customized therapy' to 'quasi-large-scale biologics.' The long-term market potential is projected to exceed tens of billions of US dollars, and it will form a competitive and complementary relationship with bispecific antibodies, TCR-T, and ADCs in tumor immunotherapy.
This report studies the global CAR-T Cell Therapy Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CAR-T Cell Therapy Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of CAR-T Cell Therapy Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CAR-T Cell Therapy Drugs total market, 2021-2032, (USD Million)
Global CAR-T Cell Therapy Drugs total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: CAR-T Cell Therapy Drugs total market, key domestic companies, and share, (USD Million)
Global CAR-T Cell Therapy Drugs revenue by player, revenue and market share 2021-2026, (USD Million)
Global CAR-T Cell Therapy Drugs total market by Targets, CAGR, 2021-2032, (USD Million)
Global CAR-T Cell Therapy Drugs total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global CAR-T Cell Therapy Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Kite Pharma, Bristol Myers Squibb?BMS?, Gilead Sciences, Johnson & Johnson, Legend Biotech, Fosun Kite, JW Therapeutics, IASO Biotherapeutics, Juventas Cell Therapy, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world CAR-T Cell Therapy Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Targets, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global CAR-T Cell Therapy Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- CD19 CAR-T
- BCMA CAR-T
- CD22 CAR-T
- Dual-target CAR-T
- Autologous CAR-T
- Universal CAR-T
- Hematologic Malignancies
- Solid Tumors
- Autoimmune Diseases
- Novartis
- Kite Pharma
- Bristol Myers Squibb?BMS?
- Gilead Sciences
- Johnson & Johnson
- Legend Biotech
- Fosun Kite
- JW Therapeutics
- IASO Biotherapeutics
- Juventas Cell Therapy
- CARsgen Therapeutics
- Bluebird Bio
- Curocell
1. How big is the global CAR-T Cell Therapy Drugs market?
2. What is the demand of the global CAR-T Cell Therapy Drugs market?
3. What is the year over year growth of the global CAR-T Cell Therapy Drugs market?
4. What is the total value of the global CAR-T Cell Therapy Drugs market?
5. Who are the Major Players in the global CAR-T Cell Therapy Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 CAR-T Cell Therapy Drugs Introduction
1.2 World CAR-T Cell Therapy Drugs Market Size & Forecast (2021 & 2025 & 2032)
1.3 World CAR-T Cell Therapy Drugs Total Market by Region (by Headquarter Location)
1.3.1 World CAR-T Cell Therapy Drugs Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.3.3 China Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.3.4 Europe Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.3.5 Japan Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.3.6 South Korea Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.3.7 ASEAN Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.3.8 India Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 CAR-T Cell Therapy Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.2 World CAR-T Cell Therapy Drugs Consumption Value by Region
2.2.1 World CAR-T Cell Therapy Drugs Consumption Value by Region (2021-2026)
2.2.2 World CAR-T Cell Therapy Drugs Consumption Value Forecast by Region (2027-2032)
2.3 United States CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.4 China CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.5 Europe CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.6 Japan CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.7 South Korea CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.8 ASEAN CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.9 India CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
3 WORLD CAR-T CELL THERAPY DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World CAR-T Cell Therapy Drugs Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CAR-T Cell Therapy Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CAR-T Cell Therapy Drugs in 2025
3.2.3 Global Concentration Ratios (CR8) for CAR-T Cell Therapy Drugs in 2025
3.3 CAR-T Cell Therapy Drugs Company Evaluation Quadrant
3.4 CAR-T Cell Therapy Drugs Market: Overall Company Footprint Analysis
3.4.1 CAR-T Cell Therapy Drugs Market: Region Footprint
3.4.2 CAR-T Cell Therapy Drugs Market: Company Product Type Footprint
3.4.3 CAR-T Cell Therapy Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CAR-T Cell Therapy Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CAR-T Cell Therapy Drugs Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: CAR-T Cell Therapy Drugs Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: CAR-T Cell Therapy Drugs Consumption Value Comparison
4.2.1 United States VS China: CAR-T Cell Therapy Drugs Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: CAR-T Cell Therapy Drugs Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based CAR-T Cell Therapy Drugs Companies and Market Share, 2021-2026
4.3.1 United States Based CAR-T Cell Therapy Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CAR-T Cell Therapy Drugs Revenue, (2021-2026)
4.4 China Based Companies CAR-T Cell Therapy Drugs Revenue and Market Share, 2021-2026
4.4.1 China Based CAR-T Cell Therapy Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CAR-T Cell Therapy Drugs Revenue, (2021-2026)
4.5 Rest of World Based CAR-T Cell Therapy Drugs Companies and Market Share, 2021-2026
4.5.1 Rest of World Based CAR-T Cell Therapy Drugs Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies CAR-T Cell Therapy Drugs Revenue (2021-2026)
5 MARKET ANALYSIS BY TARGETS
5.1 World CAR-T Cell Therapy Drugs Market Size Overview by Targets: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Targets
5.2.1 CD19 CAR-T
5.2.2 BCMA CAR-T
5.2.3 CD22 CAR-T
5.2.4 Dual-target CAR-T
5.3 Market Segment by Targets
5.3.1 World CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026)
5.3.2 World CAR-T Cell Therapy Drugs Market Size by Targets (2027-2032)
5.3.3 World CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2027-2032)
6 MARKET ANALYSIS BY CELL ORIGIN
6.1 World CAR-T Cell Therapy Drugs Market Size Overview by Cell Origin: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cell Origin
6.2.1 Autologous CAR-T
6.2.2 Universal CAR-T
6.3 Market Segment by Cell Origin
6.3.1 World CAR-T Cell Therapy Drugs Market Size by Cell Origin (2021-2026)
6.3.2 World CAR-T Cell Therapy Drugs Market Size by Cell Origin (2027-2032)
6.3.3 World CAR-T Cell Therapy Drugs Market Size Market Share by Cell Origin (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World CAR-T Cell Therapy Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hematologic Malignancies
7.2.2 Solid Tumors
7.2.3 Autoimmune Diseases
7.3 Market Segment by Application
7.3.1 World CAR-T Cell Therapy Drugs Market Size by Application (2021-2026)
7.3.2 World CAR-T Cell Therapy Drugs Market Size by Application (2027-2032)
7.3.3 World CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Novartis
8.1.1 Novartis Details
8.1.2 Novartis Major Business
8.1.3 Novartis CAR-T Cell Therapy Drugs Product and Services
8.1.4 Novartis CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Novartis Recent Developments/Updates
8.1.6 Novartis Competitive Strengths & Weaknesses
8.2 Kite Pharma
8.2.1 Kite Pharma Details
8.2.2 Kite Pharma Major Business
8.2.3 Kite Pharma CAR-T Cell Therapy Drugs Product and Services
8.2.4 Kite Pharma CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Kite Pharma Recent Developments/Updates
8.2.6 Kite Pharma Competitive Strengths & Weaknesses
8.3 Bristol Myers Squibb?BMS?
8.3.1 Bristol Myers Squibb?BMS? Details
8.3.2 Bristol Myers Squibb?BMS? Major Business
8.3.3 Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Product and Services
8.3.4 Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Bristol Myers Squibb?BMS? Recent Developments/Updates
8.3.6 Bristol Myers Squibb?BMS? Competitive Strengths & Weaknesses
8.4 Gilead Sciences
8.4.1 Gilead Sciences Details
8.4.2 Gilead Sciences Major Business
8.4.3 Gilead Sciences CAR-T Cell Therapy Drugs Product and Services
8.4.4 Gilead Sciences CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 Gilead Sciences Recent Developments/Updates
8.4.6 Gilead Sciences Competitive Strengths & Weaknesses
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Details
8.5.2 Johnson & Johnson Major Business
8.5.3 Johnson & Johnson CAR-T Cell Therapy Drugs Product and Services
8.5.4 Johnson & Johnson CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Johnson & Johnson Recent Developments/Updates
8.5.6 Johnson & Johnson Competitive Strengths & Weaknesses
8.6 Legend Biotech
8.6.1 Legend Biotech Details
8.6.2 Legend Biotech Major Business
8.6.3 Legend Biotech CAR-T Cell Therapy Drugs Product and Services
8.6.4 Legend Biotech CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Legend Biotech Recent Developments/Updates
8.6.6 Legend Biotech Competitive Strengths & Weaknesses
8.7 Fosun Kite
8.7.1 Fosun Kite Details
8.7.2 Fosun Kite Major Business
8.7.3 Fosun Kite CAR-T Cell Therapy Drugs Product and Services
8.7.4 Fosun Kite CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Fosun Kite Recent Developments/Updates
8.7.6 Fosun Kite Competitive Strengths & Weaknesses
8.8 JW Therapeutics
8.8.1 JW Therapeutics Details
8.8.2 JW Therapeutics Major Business
8.8.3 JW Therapeutics CAR-T Cell Therapy Drugs Product and Services
8.8.4 JW Therapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 JW Therapeutics Recent Developments/Updates
8.8.6 JW Therapeutics Competitive Strengths & Weaknesses
8.9 IASO Biotherapeutics
8.9.1 IASO Biotherapeutics Details
8.9.2 IASO Biotherapeutics Major Business
8.9.3 IASO Biotherapeutics CAR-T Cell Therapy Drugs Product and Services
8.9.4 IASO Biotherapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 IASO Biotherapeutics Recent Developments/Updates
8.9.6 IASO Biotherapeutics Competitive Strengths & Weaknesses
8.10 Juventas Cell Therapy
8.10.1 Juventas Cell Therapy Details
8.10.2 Juventas Cell Therapy Major Business
8.10.3 Juventas Cell Therapy CAR-T Cell Therapy Drugs Product and Services
8.10.4 Juventas Cell Therapy CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Juventas Cell Therapy Recent Developments/Updates
8.10.6 Juventas Cell Therapy Competitive Strengths & Weaknesses
8.11 CARsgen Therapeutics
8.11.1 CARsgen Therapeutics Details
8.11.2 CARsgen Therapeutics Major Business
8.11.3 CARsgen Therapeutics CAR-T Cell Therapy Drugs Product and Services
8.11.4 CARsgen Therapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 CARsgen Therapeutics Recent Developments/Updates
8.11.6 CARsgen Therapeutics Competitive Strengths & Weaknesses
8.12 Bluebird Bio
8.12.1 Bluebird Bio Details
8.12.2 Bluebird Bio Major Business
8.12.3 Bluebird Bio CAR-T Cell Therapy Drugs Product and Services
8.12.4 Bluebird Bio CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 Bluebird Bio Recent Developments/Updates
8.12.6 Bluebird Bio Competitive Strengths & Weaknesses
8.13 Curocell
8.13.1 Curocell Details
8.13.2 Curocell Major Business
8.13.3 Curocell CAR-T Cell Therapy Drugs Product and Services
8.13.4 Curocell CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 Curocell Recent Developments/Updates
8.13.6 Curocell Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 CAR-T Cell Therapy Drugs Industry Chain
9.2 CAR-T Cell Therapy Drugs Upstream Analysis
9.3 CAR-T Cell Therapy Drugs Midstream Analysis
9.4 CAR-T Cell Therapy Drugs Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 CAR-T Cell Therapy Drugs Introduction
1.2 World CAR-T Cell Therapy Drugs Market Size & Forecast (2021 & 2025 & 2032)
1.3 World CAR-T Cell Therapy Drugs Total Market by Region (by Headquarter Location)
1.3.1 World CAR-T Cell Therapy Drugs Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.3.3 China Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.3.4 Europe Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.3.5 Japan Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.3.6 South Korea Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.3.7 ASEAN Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.3.8 India Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 CAR-T Cell Therapy Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.2 World CAR-T Cell Therapy Drugs Consumption Value by Region
2.2.1 World CAR-T Cell Therapy Drugs Consumption Value by Region (2021-2026)
2.2.2 World CAR-T Cell Therapy Drugs Consumption Value Forecast by Region (2027-2032)
2.3 United States CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.4 China CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.5 Europe CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.6 Japan CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.7 South Korea CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.8 ASEAN CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
2.9 India CAR-T Cell Therapy Drugs Consumption Value (2021-2032)
3 WORLD CAR-T CELL THERAPY DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World CAR-T Cell Therapy Drugs Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CAR-T Cell Therapy Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CAR-T Cell Therapy Drugs in 2025
3.2.3 Global Concentration Ratios (CR8) for CAR-T Cell Therapy Drugs in 2025
3.3 CAR-T Cell Therapy Drugs Company Evaluation Quadrant
3.4 CAR-T Cell Therapy Drugs Market: Overall Company Footprint Analysis
3.4.1 CAR-T Cell Therapy Drugs Market: Region Footprint
3.4.2 CAR-T Cell Therapy Drugs Market: Company Product Type Footprint
3.4.3 CAR-T Cell Therapy Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CAR-T Cell Therapy Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CAR-T Cell Therapy Drugs Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: CAR-T Cell Therapy Drugs Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: CAR-T Cell Therapy Drugs Consumption Value Comparison
4.2.1 United States VS China: CAR-T Cell Therapy Drugs Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: CAR-T Cell Therapy Drugs Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based CAR-T Cell Therapy Drugs Companies and Market Share, 2021-2026
4.3.1 United States Based CAR-T Cell Therapy Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CAR-T Cell Therapy Drugs Revenue, (2021-2026)
4.4 China Based Companies CAR-T Cell Therapy Drugs Revenue and Market Share, 2021-2026
4.4.1 China Based CAR-T Cell Therapy Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CAR-T Cell Therapy Drugs Revenue, (2021-2026)
4.5 Rest of World Based CAR-T Cell Therapy Drugs Companies and Market Share, 2021-2026
4.5.1 Rest of World Based CAR-T Cell Therapy Drugs Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies CAR-T Cell Therapy Drugs Revenue (2021-2026)
5 MARKET ANALYSIS BY TARGETS
5.1 World CAR-T Cell Therapy Drugs Market Size Overview by Targets: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Targets
5.2.1 CD19 CAR-T
5.2.2 BCMA CAR-T
5.2.3 CD22 CAR-T
5.2.4 Dual-target CAR-T
5.3 Market Segment by Targets
5.3.1 World CAR-T Cell Therapy Drugs Market Size by Targets (2021-2026)
5.3.2 World CAR-T Cell Therapy Drugs Market Size by Targets (2027-2032)
5.3.3 World CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2027-2032)
6 MARKET ANALYSIS BY CELL ORIGIN
6.1 World CAR-T Cell Therapy Drugs Market Size Overview by Cell Origin: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cell Origin
6.2.1 Autologous CAR-T
6.2.2 Universal CAR-T
6.3 Market Segment by Cell Origin
6.3.1 World CAR-T Cell Therapy Drugs Market Size by Cell Origin (2021-2026)
6.3.2 World CAR-T Cell Therapy Drugs Market Size by Cell Origin (2027-2032)
6.3.3 World CAR-T Cell Therapy Drugs Market Size Market Share by Cell Origin (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World CAR-T Cell Therapy Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hematologic Malignancies
7.2.2 Solid Tumors
7.2.3 Autoimmune Diseases
7.3 Market Segment by Application
7.3.1 World CAR-T Cell Therapy Drugs Market Size by Application (2021-2026)
7.3.2 World CAR-T Cell Therapy Drugs Market Size by Application (2027-2032)
7.3.3 World CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Novartis
8.1.1 Novartis Details
8.1.2 Novartis Major Business
8.1.3 Novartis CAR-T Cell Therapy Drugs Product and Services
8.1.4 Novartis CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Novartis Recent Developments/Updates
8.1.6 Novartis Competitive Strengths & Weaknesses
8.2 Kite Pharma
8.2.1 Kite Pharma Details
8.2.2 Kite Pharma Major Business
8.2.3 Kite Pharma CAR-T Cell Therapy Drugs Product and Services
8.2.4 Kite Pharma CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Kite Pharma Recent Developments/Updates
8.2.6 Kite Pharma Competitive Strengths & Weaknesses
8.3 Bristol Myers Squibb?BMS?
8.3.1 Bristol Myers Squibb?BMS? Details
8.3.2 Bristol Myers Squibb?BMS? Major Business
8.3.3 Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Product and Services
8.3.4 Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Bristol Myers Squibb?BMS? Recent Developments/Updates
8.3.6 Bristol Myers Squibb?BMS? Competitive Strengths & Weaknesses
8.4 Gilead Sciences
8.4.1 Gilead Sciences Details
8.4.2 Gilead Sciences Major Business
8.4.3 Gilead Sciences CAR-T Cell Therapy Drugs Product and Services
8.4.4 Gilead Sciences CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 Gilead Sciences Recent Developments/Updates
8.4.6 Gilead Sciences Competitive Strengths & Weaknesses
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Details
8.5.2 Johnson & Johnson Major Business
8.5.3 Johnson & Johnson CAR-T Cell Therapy Drugs Product and Services
8.5.4 Johnson & Johnson CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Johnson & Johnson Recent Developments/Updates
8.5.6 Johnson & Johnson Competitive Strengths & Weaknesses
8.6 Legend Biotech
8.6.1 Legend Biotech Details
8.6.2 Legend Biotech Major Business
8.6.3 Legend Biotech CAR-T Cell Therapy Drugs Product and Services
8.6.4 Legend Biotech CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Legend Biotech Recent Developments/Updates
8.6.6 Legend Biotech Competitive Strengths & Weaknesses
8.7 Fosun Kite
8.7.1 Fosun Kite Details
8.7.2 Fosun Kite Major Business
8.7.3 Fosun Kite CAR-T Cell Therapy Drugs Product and Services
8.7.4 Fosun Kite CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Fosun Kite Recent Developments/Updates
8.7.6 Fosun Kite Competitive Strengths & Weaknesses
8.8 JW Therapeutics
8.8.1 JW Therapeutics Details
8.8.2 JW Therapeutics Major Business
8.8.3 JW Therapeutics CAR-T Cell Therapy Drugs Product and Services
8.8.4 JW Therapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 JW Therapeutics Recent Developments/Updates
8.8.6 JW Therapeutics Competitive Strengths & Weaknesses
8.9 IASO Biotherapeutics
8.9.1 IASO Biotherapeutics Details
8.9.2 IASO Biotherapeutics Major Business
8.9.3 IASO Biotherapeutics CAR-T Cell Therapy Drugs Product and Services
8.9.4 IASO Biotherapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 IASO Biotherapeutics Recent Developments/Updates
8.9.6 IASO Biotherapeutics Competitive Strengths & Weaknesses
8.10 Juventas Cell Therapy
8.10.1 Juventas Cell Therapy Details
8.10.2 Juventas Cell Therapy Major Business
8.10.3 Juventas Cell Therapy CAR-T Cell Therapy Drugs Product and Services
8.10.4 Juventas Cell Therapy CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Juventas Cell Therapy Recent Developments/Updates
8.10.6 Juventas Cell Therapy Competitive Strengths & Weaknesses
8.11 CARsgen Therapeutics
8.11.1 CARsgen Therapeutics Details
8.11.2 CARsgen Therapeutics Major Business
8.11.3 CARsgen Therapeutics CAR-T Cell Therapy Drugs Product and Services
8.11.4 CARsgen Therapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 CARsgen Therapeutics Recent Developments/Updates
8.11.6 CARsgen Therapeutics Competitive Strengths & Weaknesses
8.12 Bluebird Bio
8.12.1 Bluebird Bio Details
8.12.2 Bluebird Bio Major Business
8.12.3 Bluebird Bio CAR-T Cell Therapy Drugs Product and Services
8.12.4 Bluebird Bio CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 Bluebird Bio Recent Developments/Updates
8.12.6 Bluebird Bio Competitive Strengths & Weaknesses
8.13 Curocell
8.13.1 Curocell Details
8.13.2 Curocell Major Business
8.13.3 Curocell CAR-T Cell Therapy Drugs Product and Services
8.13.4 Curocell CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 Curocell Recent Developments/Updates
8.13.6 Curocell Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 CAR-T Cell Therapy Drugs Industry Chain
9.2 CAR-T Cell Therapy Drugs Upstream Analysis
9.3 CAR-T Cell Therapy Drugs Midstream Analysis
9.4 CAR-T Cell Therapy Drugs Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World CAR-T Cell Therapy Drugs Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World CAR-T Cell Therapy Drugs Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World CAR-T Cell Therapy Drugs Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World CAR-T Cell Therapy Drugs Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World CAR-T Cell Therapy Drugs Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CAR-T Cell Therapy Drugs Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World CAR-T Cell Therapy Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World CAR-T Cell Therapy Drugs Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World CAR-T Cell Therapy Drugs Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key CAR-T Cell Therapy Drugs Players in 2025
Table 12. World CAR-T Cell Therapy Drugs Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global CAR-T Cell Therapy Drugs Company Evaluation Quadrant
Table 14. Head Office of Key CAR-T Cell Therapy Drugs Players
Table 15. CAR-T Cell Therapy Drugs Market: Company Product Type Footprint
Table 16. CAR-T Cell Therapy Drugs Market: Company Product Application Footprint
Table 17. CAR-T Cell Therapy Drugs Mergers & Acquisitions Activity
Table 18. United States VS China CAR-T Cell Therapy Drugs Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China CAR-T Cell Therapy Drugs Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based CAR-T Cell Therapy Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies CAR-T Cell Therapy Drugs Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies CAR-T Cell Therapy Drugs Revenue Market Share (2021-2026)
Table 23. China Based CAR-T Cell Therapy Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies CAR-T Cell Therapy Drugs Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies CAR-T Cell Therapy Drugs Revenue Market Share (2021-2026)
Table 26. Rest of World Based CAR-T Cell Therapy Drugs Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies CAR-T Cell Therapy Drugs Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies CAR-T Cell Therapy Drugs Revenue Market Share (2021-2026)
Table 29. World CAR-T Cell Therapy Drugs Market Size by Targets, (USD Million), 2021 & 2025 & 2032
Table 30. World CAR-T Cell Therapy Drugs Market Size Value by Targets (2021-2026) & (USD Million)
Table 31. World CAR-T Cell Therapy Drugs Market Size by Targets (2027-2032) & (USD Million)
Table 32. World CAR-T Cell Therapy Drugs Market Size by Cell Origin, (USD Million), 2021 & 2025 & 2032
Table 33. World CAR-T Cell Therapy Drugs Market Size Value by Cell Origin (2021-2026) & (USD Million)
Table 34. World CAR-T Cell Therapy Drugs Market Size by Cell Origin (2027-2032) & (USD Million)
Table 35. World CAR-T Cell Therapy Drugs Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World CAR-T Cell Therapy Drugs Market Size by Application (2021-2026) & (USD Million)
Table 37. World CAR-T Cell Therapy Drugs Market Size by Application (2027-2032) & (USD Million)
Table 38. Novartis Basic Information, Manufacturing Base and Competitors
Table 39. Novartis Major Business
Table 40. Novartis CAR-T Cell Therapy Drugs Product and Services
Table 41. Novartis CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Novartis Recent Developments/Updates
Table 43. Novartis Competitive Strengths & Weaknesses
Table 44. Kite Pharma Basic Information, Manufacturing Base and Competitors
Table 45. Kite Pharma Major Business
Table 46. Kite Pharma CAR-T Cell Therapy Drugs Product and Services
Table 47. Kite Pharma CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Kite Pharma Recent Developments/Updates
Table 49. Kite Pharma Competitive Strengths & Weaknesses
Table 50. Bristol Myers Squibb?BMS? Basic Information, Manufacturing Base and Competitors
Table 51. Bristol Myers Squibb?BMS? Major Business
Table 52. Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Product and Services
Table 53. Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Bristol Myers Squibb?BMS? Recent Developments/Updates
Table 55. Bristol Myers Squibb?BMS? Competitive Strengths & Weaknesses
Table 56. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 57. Gilead Sciences Major Business
Table 58. Gilead Sciences CAR-T Cell Therapy Drugs Product and Services
Table 59. Gilead Sciences CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Gilead Sciences Recent Developments/Updates
Table 61. Gilead Sciences Competitive Strengths & Weaknesses
Table 62. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 63. Johnson & Johnson Major Business
Table 64. Johnson & Johnson CAR-T Cell Therapy Drugs Product and Services
Table 65. Johnson & Johnson CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Johnson & Johnson Recent Developments/Updates
Table 67. Johnson & Johnson Competitive Strengths & Weaknesses
Table 68. Legend Biotech Basic Information, Manufacturing Base and Competitors
Table 69. Legend Biotech Major Business
Table 70. Legend Biotech CAR-T Cell Therapy Drugs Product and Services
Table 71. Legend Biotech CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Legend Biotech Recent Developments/Updates
Table 73. Legend Biotech Competitive Strengths & Weaknesses
Table 74. Fosun Kite Basic Information, Manufacturing Base and Competitors
Table 75. Fosun Kite Major Business
Table 76. Fosun Kite CAR-T Cell Therapy Drugs Product and Services
Table 77. Fosun Kite CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Fosun Kite Recent Developments/Updates
Table 79. Fosun Kite Competitive Strengths & Weaknesses
Table 80. JW Therapeutics Basic Information, Manufacturing Base and Competitors
Table 81. JW Therapeutics Major Business
Table 82. JW Therapeutics CAR-T Cell Therapy Drugs Product and Services
Table 83. JW Therapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. JW Therapeutics Recent Developments/Updates
Table 85. JW Therapeutics Competitive Strengths & Weaknesses
Table 86. IASO Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 87. IASO Biotherapeutics Major Business
Table 88. IASO Biotherapeutics CAR-T Cell Therapy Drugs Product and Services
Table 89. IASO Biotherapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. IASO Biotherapeutics Recent Developments/Updates
Table 91. IASO Biotherapeutics Competitive Strengths & Weaknesses
Table 92. Juventas Cell Therapy Basic Information, Manufacturing Base and Competitors
Table 93. Juventas Cell Therapy Major Business
Table 94. Juventas Cell Therapy CAR-T Cell Therapy Drugs Product and Services
Table 95. Juventas Cell Therapy CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Juventas Cell Therapy Recent Developments/Updates
Table 97. Juventas Cell Therapy Competitive Strengths & Weaknesses
Table 98. CARsgen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 99. CARsgen Therapeutics Major Business
Table 100. CARsgen Therapeutics CAR-T Cell Therapy Drugs Product and Services
Table 101. CARsgen Therapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. CARsgen Therapeutics Recent Developments/Updates
Table 103. CARsgen Therapeutics Competitive Strengths & Weaknesses
Table 104. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 105. Bluebird Bio Major Business
Table 106. Bluebird Bio CAR-T Cell Therapy Drugs Product and Services
Table 107. Bluebird Bio CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Bluebird Bio Recent Developments/Updates
Table 109. Bluebird Bio Competitive Strengths & Weaknesses
Table 110. Curocell Basic Information, Manufacturing Base and Competitors
Table 111. Curocell Major Business
Table 112. Curocell CAR-T Cell Therapy Drugs Product and Services
Table 113. Curocell CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Curocell Recent Developments/Updates
Table 115. Curocell Competitive Strengths & Weaknesses
Table 116. Global Key Players of CAR-T Cell Therapy Drugs Upstream (Raw Materials)
Table 117. Global CAR-T Cell Therapy Drugs Typical Customers
Table 1. World CAR-T Cell Therapy Drugs Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World CAR-T Cell Therapy Drugs Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World CAR-T Cell Therapy Drugs Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World CAR-T Cell Therapy Drugs Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World CAR-T Cell Therapy Drugs Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CAR-T Cell Therapy Drugs Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World CAR-T Cell Therapy Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World CAR-T Cell Therapy Drugs Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World CAR-T Cell Therapy Drugs Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key CAR-T Cell Therapy Drugs Players in 2025
Table 12. World CAR-T Cell Therapy Drugs Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global CAR-T Cell Therapy Drugs Company Evaluation Quadrant
Table 14. Head Office of Key CAR-T Cell Therapy Drugs Players
Table 15. CAR-T Cell Therapy Drugs Market: Company Product Type Footprint
Table 16. CAR-T Cell Therapy Drugs Market: Company Product Application Footprint
Table 17. CAR-T Cell Therapy Drugs Mergers & Acquisitions Activity
Table 18. United States VS China CAR-T Cell Therapy Drugs Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China CAR-T Cell Therapy Drugs Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based CAR-T Cell Therapy Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies CAR-T Cell Therapy Drugs Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies CAR-T Cell Therapy Drugs Revenue Market Share (2021-2026)
Table 23. China Based CAR-T Cell Therapy Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies CAR-T Cell Therapy Drugs Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies CAR-T Cell Therapy Drugs Revenue Market Share (2021-2026)
Table 26. Rest of World Based CAR-T Cell Therapy Drugs Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies CAR-T Cell Therapy Drugs Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies CAR-T Cell Therapy Drugs Revenue Market Share (2021-2026)
Table 29. World CAR-T Cell Therapy Drugs Market Size by Targets, (USD Million), 2021 & 2025 & 2032
Table 30. World CAR-T Cell Therapy Drugs Market Size Value by Targets (2021-2026) & (USD Million)
Table 31. World CAR-T Cell Therapy Drugs Market Size by Targets (2027-2032) & (USD Million)
Table 32. World CAR-T Cell Therapy Drugs Market Size by Cell Origin, (USD Million), 2021 & 2025 & 2032
Table 33. World CAR-T Cell Therapy Drugs Market Size Value by Cell Origin (2021-2026) & (USD Million)
Table 34. World CAR-T Cell Therapy Drugs Market Size by Cell Origin (2027-2032) & (USD Million)
Table 35. World CAR-T Cell Therapy Drugs Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World CAR-T Cell Therapy Drugs Market Size by Application (2021-2026) & (USD Million)
Table 37. World CAR-T Cell Therapy Drugs Market Size by Application (2027-2032) & (USD Million)
Table 38. Novartis Basic Information, Manufacturing Base and Competitors
Table 39. Novartis Major Business
Table 40. Novartis CAR-T Cell Therapy Drugs Product and Services
Table 41. Novartis CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Novartis Recent Developments/Updates
Table 43. Novartis Competitive Strengths & Weaknesses
Table 44. Kite Pharma Basic Information, Manufacturing Base and Competitors
Table 45. Kite Pharma Major Business
Table 46. Kite Pharma CAR-T Cell Therapy Drugs Product and Services
Table 47. Kite Pharma CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Kite Pharma Recent Developments/Updates
Table 49. Kite Pharma Competitive Strengths & Weaknesses
Table 50. Bristol Myers Squibb?BMS? Basic Information, Manufacturing Base and Competitors
Table 51. Bristol Myers Squibb?BMS? Major Business
Table 52. Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Product and Services
Table 53. Bristol Myers Squibb?BMS? CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Bristol Myers Squibb?BMS? Recent Developments/Updates
Table 55. Bristol Myers Squibb?BMS? Competitive Strengths & Weaknesses
Table 56. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 57. Gilead Sciences Major Business
Table 58. Gilead Sciences CAR-T Cell Therapy Drugs Product and Services
Table 59. Gilead Sciences CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Gilead Sciences Recent Developments/Updates
Table 61. Gilead Sciences Competitive Strengths & Weaknesses
Table 62. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 63. Johnson & Johnson Major Business
Table 64. Johnson & Johnson CAR-T Cell Therapy Drugs Product and Services
Table 65. Johnson & Johnson CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Johnson & Johnson Recent Developments/Updates
Table 67. Johnson & Johnson Competitive Strengths & Weaknesses
Table 68. Legend Biotech Basic Information, Manufacturing Base and Competitors
Table 69. Legend Biotech Major Business
Table 70. Legend Biotech CAR-T Cell Therapy Drugs Product and Services
Table 71. Legend Biotech CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Legend Biotech Recent Developments/Updates
Table 73. Legend Biotech Competitive Strengths & Weaknesses
Table 74. Fosun Kite Basic Information, Manufacturing Base and Competitors
Table 75. Fosun Kite Major Business
Table 76. Fosun Kite CAR-T Cell Therapy Drugs Product and Services
Table 77. Fosun Kite CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Fosun Kite Recent Developments/Updates
Table 79. Fosun Kite Competitive Strengths & Weaknesses
Table 80. JW Therapeutics Basic Information, Manufacturing Base and Competitors
Table 81. JW Therapeutics Major Business
Table 82. JW Therapeutics CAR-T Cell Therapy Drugs Product and Services
Table 83. JW Therapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. JW Therapeutics Recent Developments/Updates
Table 85. JW Therapeutics Competitive Strengths & Weaknesses
Table 86. IASO Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 87. IASO Biotherapeutics Major Business
Table 88. IASO Biotherapeutics CAR-T Cell Therapy Drugs Product and Services
Table 89. IASO Biotherapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. IASO Biotherapeutics Recent Developments/Updates
Table 91. IASO Biotherapeutics Competitive Strengths & Weaknesses
Table 92. Juventas Cell Therapy Basic Information, Manufacturing Base and Competitors
Table 93. Juventas Cell Therapy Major Business
Table 94. Juventas Cell Therapy CAR-T Cell Therapy Drugs Product and Services
Table 95. Juventas Cell Therapy CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Juventas Cell Therapy Recent Developments/Updates
Table 97. Juventas Cell Therapy Competitive Strengths & Weaknesses
Table 98. CARsgen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 99. CARsgen Therapeutics Major Business
Table 100. CARsgen Therapeutics CAR-T Cell Therapy Drugs Product and Services
Table 101. CARsgen Therapeutics CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. CARsgen Therapeutics Recent Developments/Updates
Table 103. CARsgen Therapeutics Competitive Strengths & Weaknesses
Table 104. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 105. Bluebird Bio Major Business
Table 106. Bluebird Bio CAR-T Cell Therapy Drugs Product and Services
Table 107. Bluebird Bio CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Bluebird Bio Recent Developments/Updates
Table 109. Bluebird Bio Competitive Strengths & Weaknesses
Table 110. Curocell Basic Information, Manufacturing Base and Competitors
Table 111. Curocell Major Business
Table 112. Curocell CAR-T Cell Therapy Drugs Product and Services
Table 113. Curocell CAR-T Cell Therapy Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Curocell Recent Developments/Updates
Table 115. Curocell Competitive Strengths & Weaknesses
Table 116. Global Key Players of CAR-T Cell Therapy Drugs Upstream (Raw Materials)
Table 117. Global CAR-T Cell Therapy Drugs Typical Customers
LIST OF FIGURES
Figure 1. CAR-T Cell Therapy Drugs Picture
Figure 2. World CAR-T Cell Therapy Drugs Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World CAR-T Cell Therapy Drugs Total Revenue (2021-2032) & (USD Million)
Figure 4. World CAR-T Cell Therapy Drugs Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World CAR-T Cell Therapy Drugs Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 13. CAR-T Cell Therapy Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 16. World CAR-T Cell Therapy Drugs Consumption Value Market Share by Region (2021-2032)
Figure 17. United States CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 18. China CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 23. India CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of CAR-T Cell Therapy Drugs by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for CAR-T Cell Therapy Drugs Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for CAR-T Cell Therapy Drugs Markets in 2025
Figure 27. United States VS China: CAR-T Cell Therapy Drugs Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: CAR-T Cell Therapy Drugs Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World CAR-T Cell Therapy Drugs Market Size by Targets, (USD Million), 2021 & 2025 & 2032
Figure 30. World CAR-T Cell Therapy Drugs Market Size Market Share by Targets in 2025
Figure 31. CD19 CAR-T
Figure 32. BCMA CAR-T
Figure 33. CD22 CAR-T
Figure 34. Dual-target CAR-T
Figure 35. World CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2032)
Figure 36. World CAR-T Cell Therapy Drugs Market Size by Cell Origin, (USD Million), 2021 & 2025 & 2032
Figure 37. World CAR-T Cell Therapy Drugs Market Size Market Share by Cell Origin in 2025
Figure 38. Autologous CAR-T
Figure 39. Universal CAR-T
Figure 40. World CAR-T Cell Therapy Drugs Market Size Market Share by Cell Origin (2021-2032)
Figure 41. World CAR-T Cell Therapy Drugs Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 42. World CAR-T Cell Therapy Drugs Market Size Market Share by Application in 2025
Figure 43. Hematologic Malignancies
Figure 44. Solid Tumors
Figure 45. Autoimmune Diseases
Figure 46. World CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2032)
Figure 47. CAR-T Cell Therapy Drugs Industrial Chain
Figure 48. Methodology
Figure 49. Research Process and Data Source
Figure 1. CAR-T Cell Therapy Drugs Picture
Figure 2. World CAR-T Cell Therapy Drugs Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World CAR-T Cell Therapy Drugs Total Revenue (2021-2032) & (USD Million)
Figure 4. World CAR-T Cell Therapy Drugs Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World CAR-T Cell Therapy Drugs Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company CAR-T Cell Therapy Drugs Revenue (2021-2032) & (USD Million)
Figure 13. CAR-T Cell Therapy Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 16. World CAR-T Cell Therapy Drugs Consumption Value Market Share by Region (2021-2032)
Figure 17. United States CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 18. China CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 23. India CAR-T Cell Therapy Drugs Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of CAR-T Cell Therapy Drugs by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for CAR-T Cell Therapy Drugs Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for CAR-T Cell Therapy Drugs Markets in 2025
Figure 27. United States VS China: CAR-T Cell Therapy Drugs Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: CAR-T Cell Therapy Drugs Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World CAR-T Cell Therapy Drugs Market Size by Targets, (USD Million), 2021 & 2025 & 2032
Figure 30. World CAR-T Cell Therapy Drugs Market Size Market Share by Targets in 2025
Figure 31. CD19 CAR-T
Figure 32. BCMA CAR-T
Figure 33. CD22 CAR-T
Figure 34. Dual-target CAR-T
Figure 35. World CAR-T Cell Therapy Drugs Market Size Market Share by Targets (2021-2032)
Figure 36. World CAR-T Cell Therapy Drugs Market Size by Cell Origin, (USD Million), 2021 & 2025 & 2032
Figure 37. World CAR-T Cell Therapy Drugs Market Size Market Share by Cell Origin in 2025
Figure 38. Autologous CAR-T
Figure 39. Universal CAR-T
Figure 40. World CAR-T Cell Therapy Drugs Market Size Market Share by Cell Origin (2021-2032)
Figure 41. World CAR-T Cell Therapy Drugs Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 42. World CAR-T Cell Therapy Drugs Market Size Market Share by Application in 2025
Figure 43. Hematologic Malignancies
Figure 44. Solid Tumors
Figure 45. Autoimmune Diseases
Figure 46. World CAR-T Cell Therapy Drugs Market Size Market Share by Application (2021-2032)
Figure 47. CAR-T Cell Therapy Drugs Industrial Chain
Figure 48. Methodology
Figure 49. Research Process and Data Source
